Damora Therapeutics, Inc. Ordinary Shares Share Price
NASDAQ: DMRA
Live Damora Therapeutics, Inc. Ordinary Shares Share Price Chart
O H L
Damora Therapeutics, Inc. Ordinary Shares Performance Overview
Days Range
▼
$22.38Low
$22.38High
Markets Today
| Previous Close | $22.78 |
|---|---|
| Open | $22.38 |
| Volume | 67,134 |
| Day's Range | $22.38 - $22.38 |
| 52W Range | NA |
| Market Cap | $1.51 B |
Historical Performance
| 1M Returns | -28.36 |
|---|---|
| 3M Returns | +7.30 |
| 6M Returns | +7.71 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Damora Therapeutics, Inc. Ordinary Shares Fundamentals
| Market Cap | $1.51 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $1.51 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Damora Therapeutics, Inc. Ordinary Shares Profit & Loss
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Total Revenue + | $0 | $0 |
| Gross Profit + | $0 | $0 |
| Operating Income | -$30.81 M | -$34.99 M |
| EBITDA | -$30.81 M | -$34.99 M |
| Interest Expense | $0 | $0 |
| Depreciation | $5.00 K | $6.00 K |
| Income Before Tax | -$27.74 M | -$30.92 M |
| Income Tax Expense | $42.00 K | $255.00 K |
| Net Income + | -$27.78 M | -$31.17 M |
| Net Profit Margin | - | - |
Damora Therapeutics, Inc. Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Share Capital | $1.00 K | $1.00 K |
| Reserve & Surplus | -$514.39 M | -$545.59 M |
| Non-Current Liabilities | $27.00 K | $27.00 K |
| Current Liabilities | $23.81 M | $27.55 M |
| Total Liabilities | $23.84 M | $27.58 M |
| Fixed Assets | $0 | $0 |
| Current Assets | $535.41 M | $543.59 M |
| Total Assets | $535.44 M | $543.64 M |
Damora Therapeutics, Inc. Ordinary Shares Cash Flow
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Net Income | -$27.78 M | -$31.17 M |
| Operating Cash Flow | -$20.60 M | -$21.87 M |
| Investing Cash Flow | $0 | $0 |
| Financing Cash Flow | $295.92 M | $29.50 M |
| Change in Cash | $275.32 M | $7.64 M |
Damora Therapeutics, Inc. Ordinary Shares Return Calculator
The Damora Therapeutics, Inc. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Damora Therapeutics, Inc. Ordinary Shares
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Popular Stocks
FAQs
What is the share price of Damora Therapeutics, Inc. Ordinary Shares today?
Damora Therapeutics, Inc. Ordinary Shares (DMRA) share price as of September 18, 2026 is $22.27. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Damora Therapeutics, Inc. Ordinary Shares?
Yes, Indian Investors can invest in the Damora Therapeutics, Inc. Ordinary Shares (DMRA) Share by opening an international trading account with Angel One.
How can I purchase Damora Therapeutics, Inc. Ordinary Shares shares in India?
Purchasing Damora Therapeutics, Inc. Ordinary Shares (DMRA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Damora Therapeutics, Inc. Ordinary Shares (DMRA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Damora Therapeutics, Inc. Ordinary Shares?
Yes, you can purchase fractional shares of Damora Therapeutics, Inc. Ordinary Shares (DMRA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Damora Therapeutics, Inc. Ordinary Shares?
The market capitalization of Damora Therapeutics, Inc. Ordinary Shares on September 18, 2026, is $1.51 B.
In which sector Damora Therapeutics, Inc. Ordinary Shares belongs?
Damora Therapeutics, Inc. Ordinary Shares operates in the null sector, specifically in the null industry.
What documents are required to invest in Damora Therapeutics, Inc. Ordinary Shares stocks?
In order to invest in Damora Therapeutics, Inc. Ordinary Shares (DMRA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
